Interim report
Page 1
RNS Number : 9080U Advanced Medical Solutions Grp PLC 16 September 2026 16 September 2026 Advanced Medical Solutions Group plc ( " AMS " or the " Group " ) Interim results for the six months ended 30 June 2026 Winsford , UK , 16 September 2026 : Advanced Medical Solutions Group plc ( AIM : AMS ) , a world - leading specialist in tissue - healing technologies , today announces its unaudited interim results for the six months ended 30 June 2026 ( the " Period " ) . Change at H1 H1 2026 2025 Reported change¹ constant currency² Surgical Business Unit ( £ million ) + 2 % 91.4 87.9 + 4 % Advanced Woundcare Business Unit ( £ million ) + 5 % 24.1 22.9 + 5 % Total group revenue ( £ million ) + 3 % 115.5 110.8 + 4 % Adjusted Measures Adjusted EBITDA ( £ million ) Adjusted EBITDA margin % 26.3 24.4 + 8 % 22.7 % 22.0 % + 0.7pp Adjusted³ profit before tax ( £ million ) 18.1 16.4 + 11 % Adjusted profit before tax margin % 15.7 % 14.8 % + 0.9pp Adjusted diluted earnings per share ( p ) 6.25 5.67 + 10 % Reported Measures Profit before tax ( £ million ) 0.3 8.5 -96 % Profit before tax margin % 0.3 % 7.6 % -7.3pp Diluted earnings per share ( p ) ( 0.03 ) 2.84 -101 % Net cash inflow from operating activities ( £ 7.4 15.1 -51 % million ) Net debt 5 ( £ million ) ( 60.3 ) ( 50.1 ) + 20 % Interim dividend per share ( p ) Nil 0.85 -100 % Financial and Operational Highlights : Group revenue increased by 4 % to £ 115.5 million and by 3 % at constant currency ( 2025 H1 : £ 110.8 million ) with overall growth partially offset by lower Adhesives sales linked to partner order phasing : O Surgical revenues increased by 4 % on a reported basis and 2 % on a constant currency basis to £ 91.4 million ( 2025 H1 : £ 87.9 million ) with growth across the majority of AMS ' products categories § As reported in the prior year , US LiquiBandⓇ benefited from significant partner order phasing in H1 2025 creating a high comparator for this Period . Consequently , revenues in the Period were 15 % lower at reported currency and 14 % lower at constant currency vs the comparative period